Initiating antiretroviral therapy (ART) during tuberculosis therapy significantly reduced mortality rates by 56 percent in a randomized clinical trial of 642 patients co-infected with HIV and ...

Patients receiving rifampicin-based anti-tuberculosis therapy are more likely to experience virological failure when starting nevirapine-based antiretroviral therapy, an HIV treatment that is widely ...

Taking a new approach toward tuberculosis therapy, a UCLA-led research team has devised a potential drug regimen that could cut the treatment time by up to 75 percent, while simultaneously reducing ...

Tuberculosis is the infectious disease with the highest death rate worldwide. As reported by WHO, therapy-resistant tuberculosis infections are increasing. Diseases due to this bacterial infection may ...

Integrating tobacco-cessation services into HIV and tuberculosis care can enhance treatment outcomes and reduce mortality. Health systems should implement comprehensive tobacco-cessation strategies, ...

Scientists at UCLA and Shanghai Jiao Tong University say they have made an important step toward a substantially faster and more effective treatment for tuberculosis, which infects some 10 million ...

Four months of multi-drug therapy that included rifapentine and moxifloxacin treated active tuberculosis (TB) as effectively as the standard six-month regimen in a multinational study, cutting ...

Please provide your email address to receive an email when new articles are posted on . BOSTON — Researchers reported that the immediate initiation of isoniazid preventive therapy for tuberculosis ...

The US Centers for Disease Control and Prevention (CDC) published guidelines for the prevention of tuberculosis specifically in the setting of TNF blockade in 2005. [9] Before a patient starts ...